Atossa Therapeutics
ATOS
#9542
Rank
ยฃ53.32 M
Marketcap
ยฃ0.41
Share price
-5.83%
Change (1 day)
-39.59%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -ยฃ22.86 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.64 Million, an increase over its 2023 earnings that were of -ยฃ22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ22.86 Million22.65%
2024 -ยฃ18.64 Million-15.25%
2023 -ยฃ22 Million11.62%
2022 -ยฃ19.71 Million30.84%
2021 -ยฃ15.06 Million15.58%
2020 -ยฃ13.03 Million3.41%
2019 -ยฃ12.6 Million51.16%
2018 -ยฃ8.34 Million40.41%
2017 -ยฃ5.94 Million27.54%
2016 -ยฃ4.66 Million-47.49%
2015 -ยฃ8.87 Million-17.25%
2014 -ยฃ10.72 Million35.91%
2013 -ยฃ7.89 Million112.3%
2012 -ยฃ3.72 Million46.53%
2011 -ยฃ2.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.67 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ0.94 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ0.97 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ30.45 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ79.81 Million 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.73 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA